Two common, functional polymorphisms in the promoter region of the β- fibrinogen gene contribute to regulation of plasma fibrinogen concentration

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 19, Issue 12, 1999, Pages 3063-3070

  Van 'T Hooft, Ferdinand M ^a   Von Bahr, Sara J F ^a   Silveira, Angela ^a   Iliadou, Anastasia ^b   Eriksson, Per ^a   Hamsten, Anders ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

455G A polymorphism; 845G A polymorphism; DNA; Fibrinogen; fibrinogen gene

Indexed keywords

DNA; FIBRINOGEN; NUCLEAR PROTEIN; NUCLEOTIDE;

ADULT; ARTICLE; CELL STRAIN HEPG2; CONTROLLED STUDY; DNA POLYMORPHISM; FIBRINOGEN BLOOD LEVEL; FIBRINOGEN SYNTHESIS; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; PRIORITY JOURNAL; PROMOTER REGION;

EID: 0033387742     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.19.12.3063     Document Type: Article

References (42)

1. McDonald L, Edgill M. Coagulability of the blood in ischaemic heart disease. Lancet. 1957;2:457-460.
2. Phear D, Stirland R. The value of estimating fibrinogen and C-reactive protein levels in myocardial ischaemia. Lancet. 1957;2:270-275.
3. Wilhelmsen L, Svärdsudd K, Korsan-Bengsten K, Larsson B, Welin L, Tibblin G. Fibrinogen as a risk factor for stroke and myocardial infarction. N Engl J Med. 1984;311:501-505.
4. Meade TW, Mellows S, Brozovic M, Miller GJ, Chakrabarti RR, North WRS Haines AP, Stirling Y, Imeson JD, Thompson SG. Haemostatic function and ischaemic heart disease: principal results of the Northwick Park Heart Study. Lancet. 1986;2:533-537.
5. Kannel WB, Wolf PA, Castelli WP, D'Agostino RB. Fibrinogen and risk of cardiovascular disease: the Framingham Study. JAMA. 1987;258: 1183-1186.
6. Yarnell JW, Baker IA, Sweetnam PM, Bainton D, O'Brien JR, Whitehead PJ. Elwood PC. Fibrinogen, viscosity, and white blood cell count are major risk factors for ischemic heart disease: the Caerphilly and Speedwell collaborative heart disease studies. Circulation. 1991;83: 836-844.
7. Heinrich J, Balleisen L, Schulte H, Assmann G, van de Loo J. Fibrinogen and factor VII in the prediction of coronary risk: results from the PROCAM study in healthy men. Arterioscler Thromb. 1994;14:54-59.
8. Ernst E, Resch KL. Fibrinogen as a cardiovascular risk factor: a meta-analysis and review of the literature. Ann Intern Med. 1993;118:956-963.
9. Qizilbash N, Jones L, Warlow C, Mann J. Fibrinogen and lipid concentrations as risk factors for transient ischaemic attacks and minor ischaemic strokes. BMJ. 1991;303:605-609.
10. Fowkes FG, Connor JM, Smith FB, Wood J, Donnan PT, Lowe GDO. Fibrinogen genotype and risk of peripheral atherosclerosis. Lancet. 1992; 339:693-696.
11. Balleisen L, Bailey J, Epping P-H, Schulte H, van der Loo J. Epidemiological study on factor VII, factor VIII and fibrinogen in an industrial population, I: baseline data on the relation to age, gender, body-weight, smoking, alcohol, pill-using and menopause. Thromb Haemost. 1985;54: 475-479.
12. Meade TW, Imeson J, Stirling Y. Effects of changes in smoking and other characteristics on clotting factors and the risk of ischaemic heart disease. Lancet. 1987;2:986-988.
13. Tybjaerg-Hansen A, Agerholm-Larsen B, Humphries SE, Abildgaard S, Schnohr P, Nordestgaard BG. A common mutation (G-455-A) in the β-fibrinogen promoter is an independent predictor of plasma fibrinogen, but not of ischemic heart disease. J Clin Invest. 1997;99:3034-3039.
14. Hamsten A, Iselius L, de Faire U, Blombäck M. Genetic and cultural inheritance of plasma fibrinogen concentration. Lancet. 1987;2:988-991.
15. Bara L, Nicaud V, Tiret L, Cambien F, Samama MM, for the European Atherosclerosis Research Study Group. Expression of a paternal history of premature myocardial infarction on fibrinogen, factor VIIC and PAI-1 in European offspring: the EARS study. Thromb Haemost. 1994;71: 434-440.
16. Livshits G, Blettner M, Graff E, Hoting I, Schettler G, Brunner D. The Tel Aviv-Heidelberg three-generation offspring study: genetic determinants of plasma fibrinogen. Atherosclerosis. 1995;115(suppl):S119. Abstract.
17. Berg K, Kierulf P. DNA polymorphisms at fibrinogen loci and plasma fibrinogen concentration. Clin Genet. 1989;36:229-235.
18. Reed T, Tracy RP, Fabsitz RR. Minimal genetic influences on plasma fibrinogen level in adult males in the NHLBI twin study. Clin Genet. 1994;45:71-77.
19. Chung DW, Harris JE, Davie EW. Nucleotide sequences of the three genes coding for human fibrinogen. In: Lui CY, Chien C, eds. Fibrinogen, Thrombosis, Coagulation, and Fibrinolysis. New York, NY: Plenum Press; 1990:39-47.
20. Roy SN, Mukhopadhyay G, Redman CM. Regulation of fibrinogen assembly: transfection of HepG2 cells with Bβ cDNA specifically enhances synthesis of the three component chains of fibrinogen. J Biol Chem. 1990;265:6389-6393.
21. Thomas AE, Green FR, Kelleher CH, Wilkes HC, Brennan PJ, Meade TW, Humphries SE. Variation in the promoter region of the β-fibrinogen gene is associated with plasma fibrinogen levels in smokers and non-smokers. Thromb Haemost. 1991;65:487-490.
22. Baumann RE, Henschen AH. Human fibrinogen polymorphic site analysis by restriction endonuclease digestion and allele-specific polymerase chain reaction amplification: identification of polymorphisms at positions Aα312 and Bβ448. Blood. 1993;82:2117-2124.
23. Behague I, Poirier O, Nicaud V, Evans A, Arveiler D, Luc G, Cambou J-P, Scarabin P-Y, Bara L, Green F, Cambien F. β-Fibrinogen gene polymorphisms are associated with plasma fibrinogen and coronary artery disease in patients with myocardial infarction: the ECTIM Study. Circulation. 1996;93:440-449.
24. Baumann RE, Henschen AH. Linkage disequilibrium relationships among four polymorphisms within the human fibrinogen gene cluster. Hum Genet. 1994;94:165-170.
25. Moor E, Silveira A, van 't Hooft F, Suontaka AM. Eriksson P, Blombäck M, Hamsten A. Coagulation factor VII mass and activity in young men with myocardial infarction at a young age: role of plasma lipoproteins and factor VII genotype. Arterioscler Thromb Vasc Biol. 1995;15:655-664.
26. Clauss A. Gerinnungsphysiologische Schnellmethode zur Bestimmung des Fibrinogens. Acta Haematol. 1957;17:237-246.
27. Sambrook J, Fritsch EF, Maniatis T. Molecular Cloning: A Laboratory Manual. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press; 1989.
28. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 1988; 16:1215.
29. Lew DJ, Decker T, Strehlow I, Darnell JE. Overlapping elements in the guanylate-binding protein gene promoter mediate transcriptional induction by alpha and gamma interferons. Mol Cell Biol. 1991;11: 182-191.
30. Alksnis M, Barkhem T, Strömstedt P-E, Ahola H, Kutoh E, Gustafsson J-Å, Poellinger L, Nilsson S. High level expression of functional full length and truncated glucocorticoid receptor in Chinese hamster ovary cells: demonstration of ligand-induced down-regulation of expressed receptor mRNA and protein. J Biol Chem. 1991;266:10078-10085.
31. Kalb VF Jr, Bernlohr RW. A new spectrophotometric assay for protein in cell extracts. Anal Biochem. 1977;82:362-371.
32. Dawson SJ, Wiman B, Hamsten A, Green F, Humphries S, Henney AM. The two allele sequences of a common polymorphism in the promoter of the plasminogen activator inhibitor-1 (PAI-1) gene respond differently to interleukin-1 in HepG2 cells. J Biol Chem. 1993;268:10739-10745.
33. Ott J. Analysis of Human Genetic Linkage. Baltimore, Md: John Hopkins University Press; 1991.
34. Sing CF, Davignon J. Role of the apolipoprotein E polymorphism in determining normal plasma lipid and lipoprotein variation. Am J Hum Genet. 1985;37:268-285.
35. +1689(AvaII), and BclI β-fibrinogen and TaqI α-fibrinogen, and their detection by PCR. Hum Mutat. 1994;3:79-81.
36. Brown ET, Fuller GM. Detection of a complex that associates with the B/3 fibrinogen -455G-A polymorphism. Blood. 1998;92:3286-3293.
37. Scarabin P-Y, Bara L, Ricard S, Poirier O, Cambou JP, Arveiler D, Luc G, Evans AE, Samama MM, Cambien F. Genetic variation at the β-fibrinogen locus in relation to plasma fibrinogen concentrations and risk for myocardial infarction: the ECTIM Study. Arterioscler Thromb. 1993;13:886-891.
38. Green F, Hamsten A, Blombäck M, Humphries S. The role of β-fibrinogen genotype in determining plasma fibrinogen levels in young survivors of myocardial infarction and healthy controls from Sweden. Thromb Haemost. 1993;70:915-920.
39. de Maat MPM, de Knijff P, Green FR, Thomas AE, Jespersen J, Kluft C. Gender-related association between β-fibrinogen genotype and plasma fibrinogen levels and linkage disequilibrium at the fibrinogen locus in Greenland Inuit. Arterioscler Thromb Vasc Biol. 1995;15:856-860.
40. -455-A β-gene) is associated with differences in plasma fibrinogen levels in young men and women from different regions in Europe: evidence for gender-genotype-environment interaction. Arterioscler Thromb Vasc Biol. 1995;15:96-104.
41. Heinrich J, Funke H, Rust S, Schulte H, Schönfeld R, Köhler E, Assmann G. Impact of polymorphisms in the alpha- and beta-fibrinogen gene on plasma fibrinogen concentrations of coronary heart disease patients. Thromb Res. 1995;77:209-215.
42. -455 polymorphism, age and smoking. Clin Genet. 1996;50:184-190.